Biogen Stock Surges on Analyst Rating, Market Rally
Update: 2025-12-19
Description
Biogens stock surged by 2.1% after RBC Capital reaffirmed its Outperform rating and set a price target of $210, making it a top large-cap pick for 2026. The broader market also rallied due to hints of potential interest rate adjustments, boosting Biogens shares near its 52-week high. This episode underscores the impact of analyst ratings and economic signals on individual stock performance.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
